The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
Open accessAbstract
CONTEXT: Neuroblastoma is diagnosed over a wide age range from birth through young adulthood, and older age at diagnosis is associated with a decline in survivability. OBJECTIVE: To identify genetic mutations that are associated with age at diagnosis in patients with metastatic neuroblastoma. DESIGN, SETTING, AND PATIENTS: Whole genome sequencing was performed on DNA from diagnostic tumors and their matched germlines from 40 patients with metastatic neuroblastoma obtained between 1987 and 2009. Age groups at diagnosis included infants (0-<18 months), children (18 months-<12 years), and adolescents and young adults (≥12 years). To confirm the findings from this discovery cohort, validation testing using tumors from an additional 64 patients obtained between 1985 and 2009 also was performed. Formalin-fixed, paraffin-embedded tumor tissue was used for immunohistochemistry and fluorescence in situ hybridization. Telomere lengths were analyzed using whole genome sequencing data, quantitative polymerase chain reaction, and fluorescent in situ hybridization. MAIN OUTCOME MEASURE: Somatic recurrent mutations in tumors from patients with neuroblastoma correlated with the age at diagnosis and telomere length. RESULTS: In the discovery cohort (n = 40), mutations in the ATRX gene were identified in 100% (95% CI, 50%-100%) of tumors from patients in the adolescent and young adult group (5 of 5), in 17% (95% CI, 7%-36%) of tumors from children (5 of 29), and 0% (95% CI, 0%-40%) of tumors from infants (0 of 6). In the validation cohort (n = 64), mutations in the ATRX gene were identified in 33% (95% CI, 17%-54%) of tumors from patients in the adolescent and young adult group (9 of 27), in 16% (95% CI, 6%-35%) of tumors from children (4 of 25), and in 0% (95% CI, 0%-24%) of tumors from infants (0 of 12). In both cohorts (N = 104), mutations in the ATRX gene were identified in 44% (95% CI, 28%-62%) of tumors from patients in the adolescent and young adult group (14 of 32), in 17% (95% CI, 9%-29%) of tumors from children (9 of 54), and in 0% (95% CI, 0%-17%) of tumors from infants (0 of 18). ATRX mutations were associated with an absence of the ATRX protein in the nucleus and with long telomeres. CONCLUSION: ATRX mutations were associated with age at diagnosis in children and young adults with stage 4 neuroblastoma. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00588068.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
Association of Multiple Copies of the N-myc Oncogene with Rapid Progression of Neuroblastomas
Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., & Hammond, D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510313131802 · Cited by 2,010
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Cohn, S. L., Pearson, A. D. J., London, W. B., Monclair, T., Ambros, P. F., Brodeur, G. M., Faldum, A., Hero, B., Iehara, T., Machin, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6785 · Cited by 1,910
Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A., et al. (2011) · Science · doi:10.1126/science.1200609 · Cited by 1,717
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596 · cited 5×
“ATRX mutation Yes 0 (0) [0-17] 9 (17) [9-29] 14 (44) [28-62] .”
BackgroundInfluentialDistinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions
Goldberg, A. D., Banaszynski, L. A., Noh, K.-M., Lewis, P. W., Elsaesser, S. J., Stadler, S., Dewell, S., Law, M., Guo, X., Li, X., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.003 · Cited by 1,280
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Heaphy, C. M., de Wilde, R. F., Jiao, Y., Klein, A. P., Edil, B. H., Shi, C., Bettegowda, C., Rodriguez, F. J., Eberhart, C. G., Hebbar, S., et al. (2011) · Science · doi:10.1126/science.1207313 · Cited by 1,083
Targeted expression of MYCN causes neuroblastoma in transgenic mice
Weiss, W. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.2985 · Cited by 870
Lewis, P. W., Elsaesser, S. J., Noh, K.-M., Stadler, S. C., & Allis, C. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008850107 · Cited by 821
Drané, P., Ouararhni, K., Depaux, A., Shuaib, M., & Hamiche, A. (2010) · Genes & Development · doi:10.1101/gad.566910 · Cited by 669
A novel retinoblastoma therapy from genomic and epigenetic analyses
Zhang, J., Benavente, C. A., McEvoy, J., Flores-Otero, J., Ding, L., Chen, X., Ulyanov, A., Wu, G., Wilson, M., Wang, J., et al. (2012) · Nature · doi:10.1038/nature10733 · Cited by 516
CREST maps somatic structural variation in cancer genomes with base-pair resolution
Wang, J., Mullighan, C. G., Easton, J., Roberts, S., Heatley, S. L., Ma, J., Rusch, M. C., Chen, K., Harris, C. C., Ding, L., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1628 · Cited by 496
Law, M. J., Lower, K. M., Voon, H. P. J., Hughes, J. R., Garrick, D., Viprakasit, V., Mitson, M., De Gobbi, M., Marra, M., Morris, A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.023 · Cited by 444
London, W. B., Castel, V., Monclair, T., Ambros, P. F., Pearson, A. D. J., Cohn, S. L., Berthold, F., Nakagawara, A., Ladenstein, R. L., Iehara, T., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.3392 · Cited by 318
A Quantitative Real-Time PCR Method for Absolute Telomere Length
O’Callaghan, N. J., Dhillon, V. S., Thomas, P., & Fenech, M. (2008) · BioTechniques · doi:10.2144/000112761 · Cited by 250
Interval between symptom onset and diagnosis of pediatric solid tumors
Pollock, B. H., Krischer, J. P., & Vietti, T. J. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80287-2 · Cited by 176
Alpha thalassaemia-mental retardation, X linked
Gibbons, R. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-15 · Cited by 160
Cotterill, S. J., Pearson, A. D. J., Pritchard, J., Foot, A. B. M., Roald, B., Kohler, J. A., & Imeson, J. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00058-7 · Cited by 152
Garaventa, A., Parodi, S., Bernardi, B. D., Dau, D., Manzitti, C., Conte, M., Casale, F., Viscardi, E., Bianchi, M., D’Angelo, P., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.06.010 · Cited by 129
Neuroblastoma in adolescents: The Italian experience
Conte, M., Parodi, S., Bernardi, B. D., Milanaccio, C., Mazzocco, K., Angelini, P., Viscardi, E., Cataldo, A. D., Luksch, R., & Haupt, R. (2006) · Cancer · doi:10.1002/cncr.21751 · Cited by 79
Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma
Deyell, R. J., & Attiyeh, E. F. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.03.001 · Cited by 62
Neuroblastoma in Adults and Adolescents. An Indolent Course With Poor Survival
Franks, L. M., Bollen, A. W., Seeger, R. C., Stram, D. O., & Matthay, K. K. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63326-3 · Cited by 56
DNA copy number, including telomeres and mitochondria, assayed using next-generation sequencing
Castle, J. C., Biery, M. C., Bouzek, H. K., Xie, T., Chen, R., Misura, K. M. S., Jackson, S., Armour, C. D., Johnson, J. M., Rohl, C. A., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-244 · Cited by 55
Chronic neuroblastoma: Indolent Stage 4 disease in children
Kushner, B. H., Kramer, K., & Cheung, N. V. (2002) · Cancer · doi:10.1002/cncr.10800 · Cited by 28
Self-citation
Cited by
The landscape of genomic alterations across childhood cancers
ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature · doi:10.1038/nature25480 · Cited by 1,572
Matthay, K. K., Maris, J. M., Schleiermacher, G., Nakagawara, A., Mackall, C. L., Diller, L., & Weiss, W. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.78 · Cited by 1,419
The genetic landscape of high-risk neuroblastoma
Pugh, T. J., Morozova, O., Attiyeh, E. F., Asgharzadeh, S., Wei, J. S., Auclair, D., Carter, S. L., Cibulskis, K., Hanna, M., Kiezun, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2529 · Cited by 1,186
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
Pinto, N. R., Applebaum, M. A., Volchenboum, S. L., Matthay, K. K., London, W. B., Ambros, P. F., Nakagawara, A., Berthold, F., Schleiermacher, G., Park, J. R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4648 · Cited by 911
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Cheung, N.-K. V., & Dyer, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3526 · Cited by 801
Self-citation
Metadata
- Authors
- Cheung, N.-K. V.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-03-14
- Volume
- 307
- Issue
- 10
- Pages
- 1062
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2140360759
- Cited by
- 468
- References
- 24
- FWCI
- 22.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.